ANTX vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

ANTX

46.9
AI Score
VS
ANTX Wins

JBIO

46.8
AI Score

Investment Advisor Scores

ANTX

47score
Recommendation
HOLD

JBIO

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ANTX JBIO Winner
Net Income -18.20M -96.13M ANTX
Operating Income -19.45M -102.36M ANTX
ROE -24.0% -21.9% JBIO
ROA -22.3% -20.4% JBIO
Total Assets 81.68M 472.11M JBIO
Cash 44.32M 107.25M JBIO
Current Ratio 14.32 14.93 JBIO

Relative Price Performance (Last 90 Days)

ANTX 1M: +18.1% · 3M: +18.8% JBIO 1M: +8.8% · 3M: -9.0%

Current Technical Phase

ANTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 56

RSI (14): 56.4 · Price: $5.81

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $21.34

Fundamentals Snapshot

Metric ANTX JBIO
Market Cap
Forward P/E -7.3 -8.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.05 -1.01
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ANTX is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.